单次高强度运动增强利妥昔单抗在体外对人慢性淋巴细胞白血病 B 细胞的疗效 A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo. PubMed 2024/03/17 发表Brain Behav ImmunQ1 · IF 7.5(JCR 2025) 靶点:CD19靶点:CD20靶点:CD5技术:NK 细胞慢性淋巴细胞白血病地区:欧洲